undefined undefined
NaN.000
NaN.00%
文|氨基观察 一款新药优异的早期临床数据,往往能激发大药企的并购热情,成为BD交易的重要催化剂。 在创新药领域,不乏药企在重要会议上公布亮眼数据后,随即被大药...
04-28 12:14
Cullinan Therapeutics (NASDAQ:CGEM) drew Wall Street's attention last week as William Blair touted the stock after peer-reviewed data for Amgen's (NASDAQ:AMGN) leukemia therapy, Blincyto, which target...
04-28 03:39
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences...
04-27 03:15
The health sector had 20 companies reporting their quarterly earnings this week, with 19 of them beating profit estimates for the quarter. XLV traded up 2.60% compared to the broader S&P 500 sector’s ...
04-27 00:56
RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $76 to $74.
04-26 23:46
Gilead Sciences (NASDAQ:GILD) declares $0.77/share quarterly dividend, in line with previous. Forward yield 4.7% Payable June 27; for shareholders of record June 14; ex-div June 14. See GILD Dividend ...
04-26 22:26
Shares of Biodexa (NASDAQ:BDRX) soared 126% in early trading Friday after the company announced it had entered into an exclusive worldwide license to develop and commercialize eRapa, also known as rap...
04-26 21:56
Meta绩后暴跌!隔夜现多笔看涨期权大单反向押注;谷歌期权成交量环比激增3倍,Q1业绩井喷,多头押中宝>>
04-26 20:03
Companies in the Healthcare sector have received a lot of coverage today as ana...
04-26 18:42
Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Hold.
04-26 18:21